Clinical study of upper gastrointestinal bleeding associated with low-dose aspirin in Japanese patients

Hepato-Gastroenterology

Volumn 56, Issue 96, 2009, Pages 1665-1669

  Okada, Kazuhisa ^a   Inamori, Masahiko ^b   Imajo, Kento ^a   Chiba, Hideyuki ^a   Nonaka, Takashi ^a   Shiba, Tadahiko ^a   Sakaguchi, Takashi ^a   Atsukawa, Kazuhiro ^a   Takahashi, Hisao ^a   Hoshino, Etsuo ^c   Nakajima, Atsushi ^b  

^a Hiratsuka City Hospital   (Japan)

^b YOKOHAMA CITY UNIVERSITY HOSPITAL   (Japan)

^c CANCER INSTITUTE HOSPITAL   (Japan)

Author keywords

Gastrointestinal bleeding; Histamine type2 receptor antagonist; Low dose aspirin; Proton pump inhibitor

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIULCER AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; INSULIN; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ESOPHAGOGASTRODUODENOSCOPY; FEMALE; HUMAN; JAPANESE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; PREVALENCE; PRIORITY JOURNAL; UPPER GASTROINTESTINAL BLEEDING;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PEPTIC ULCER; RISK FACTORS;

EID: 74949120881     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Patrono C: Aspirin as an antiplatelet drug. N Engl J Med 1994; 330:1287-94.
2. Weil J, Colin-Jones D, Langman M, Lawson D, Logan R, Murphy M, Rawlins M, Vessey M, Wainwright P: Prophylactic aspirin and risk of peptic ulcer bleeding. BMJ 1995; 310:827-30.
3. Cryer B, Feldman M: Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humans. Gastroenterology 1999; 117:17-25.
4. Robinson MG, Griffin JW Jr, Bowers J, Kogan FJ, Kogut DG, Lanza FL, Warner CW: Effect of ranitidine on gastroduodenal mucosal damage induced by nonsteroidal antiinflammatory drugs. Dig Dis Sci 1989; 34:424-428.
5. Graham DY, Agrawal NM, Roth SH: Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial. Lancet 1988; 2:1277-1280.
6. Soil AH: Consensus conference. Medical treatment of peptic ulcer disease. JAMA 1996; 275:622-629.
7. De Abajo FJ, Rodriguez LAG: Risk of upper gastrointestinal bleeding and perforation associated with low-dose aspirin as plain and enteric coated formulations. BMC Clin Pharmacol 2001;1:1.
8. Kelly JP, Kaufman DW, Jurgelon JM, Sheehan J, Koff RS, Shapiro S: Risk of aspirin-associated major upper gastrointestinal bleeding with enteric-coated buffered product. Lancet 1996; 349:1413-1416.
9. Kimmy MB: Cardioprotective effects and gastrointestinal risks of aspirin : maintaining the delicate balance. Am J Med 2004; 117:72S-78S.
10. Lanas A, Bajador E, Serrano P, Fuentes J, Carreno S, Guardia J, Sanz M, Montoro M, Sáinz R: Nitorvasodialators, loe-dose aspirin, other nonsteroidal anti-inflammatory drugs, and the risk of upper gastrointestinal bleeding. N Engl J Med 2000; 343:834-839.
11. Skander MP, Ryan FP: Non-steroidal anti-inflammatory drugs and pain free peptic ulceration in the elderly. Br Med J 1988; 297:833-834.
12. Sakamoto C, Sugano K, Ota S, Sakaki N, Takahashi S et al: Case-Control study on the association of upper gastrointestinal bleeding and nonsteroidal anti-inflammatory drugs in Japan. Eur J Pharmacol 2006; 62:765-772.
13. Sorensen HT, Mellemkjaer L, Blot WJ, Nielsen GL, Steffensen FH, McLaughlin JK, Olsen JH: Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin. Am J Gastroeterol 2000; 95:2218-2224.
14. Derry S, Loke YK: Risk of gastrointestinal hemorrhage with long term use of aspirin: meta-analysis. BMJ 2000; 321;1183-1187.
15. Hanssson L. Zanchetti A: Carruthers SG et al:Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principle results of the Hypertension optimal Treatment (HOT) randomized trial. HOT Study Group. Lancet 1998; 351:1755-62.
16. Physician's health study: aspirin and primary prevention of coronary heart disease. N Engl J Med 1989; 321:1825-8.
17. Serrano P, Lanas A, Arroyo MT, Ferreira IJ: Risk of upper gastrointestinal bleeding in patients taking low-dose aspirin for prevention of cardiovascular diseases. Aliment Pharmacol Ther 2002; 16:1945-1953.
18. Langman MJ, Weil J: Wainwright P et al. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994; 343:1075-8.
19. Garcia-Rodriguez LA, Jick H: Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994; 343:769-72.
20. Taha AS, Hudson N, Hawkey CJ, Swannell AJ, Trye PN, Cottrell J, Mann SG, Simon TJ, Sturrock RD, Russell RI: Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs. N Engl J Med 1996; 334:1435-1439.
21. Raskin JB: Gastrointestinal effects of nonsteroidal anti-inflammatory therapy. Am J Med 1999; 275:622-629.
22. Lanas A, Fuentes J, Benito R, Serrano P, Bajador E, Sainz R: Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low-dose aspirin. Aliment Pharmacol Ther 2002; 16:779-786.
23. Yeomans ND, Tulassay Z, Juhász L, Rácz I, Howard JM, van Rensburg CJ, Swannell AJ, Hawkey CJ: A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group. N Engl J Med 1998;338:719-726.
24. Hawkey CJ, Karrasch JA, Szczepanski L, Walker DG, Barkun A, Swannell AJ, Yeomans ND: Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group. N Engl J Med 1998; 338:727-734.
25. Graham DY, Agrawal NM, Campbell DR, Haber MM, Collis C, Lukasik NL, Huang B: NSAID-Associated Gastric Ulcer Prevention Study Group: Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole. Arch Intern Med 2002;162:169-175.
26. Lanas A, Ferrandez A: Treatment and prevention for a trial of aspirin-induced gastroduodenal ulcers and gastrointestinal bleeding. Expert Opin Drug Saf 2002;1:245-52.
27. Laine L, Harper S, Simon T, Bath R, Johanson J, Schwartz H, Stern S, Quan H, Bolognese J: A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of Ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis. Rofecoxib Osteoarthritis Endoscopy Study Group. Gastroenterology 1999; 117:776-783.
28. Emery P, Zeidler H, Kvien TK, Guslandi M, Naudin R, Stead H, Verburg KM, Isakson PC, Hubbard RC, Geis GS: Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison. Lancet 1999;354:2106-2111.
29. Goldstein JL, Correa P, Zhao WW, Burr AM, Hubbard RC, Verburg KM, Geis GS: Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritis. Am J Gastroenterol 2001;96:1019-1027.
30. Chan FK, Hung LC, Suen BY, Wu JC, Lee KC, Leung VK, Hui AJ, To KF, Leung WK, Wong VW, Chung SC, Sung JJ: Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis. N Engl J Med 2002; 347:2104-2110.
31. Raskin JB, White RH, Jaszewski R, Korsten MA, Schubert TT, Fort JG: Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: a prospective, double-blind, multicenter study. Am J Gastroenterol 1996;91:223-227.
32. Rostom A, Dube C, Wells G, Tugwell P, Welch V, Jolicoeur E, McGowan J: Prevention of NASAID-induced gastroduodenal ulcere. Cochrane Database Syst Rev. 2000;(4):CD002296.
33. Miglioli M, Bianchi Porro G, Vaira D, Menegatti M, Brunetti G, Petrillo M, Ardizzone S, Frizziero L, Montrone F, Grandinetti G: Prevention with sucralfate gel of NSAID-induced gastroduodenal damage in arthritic patients. Am J Gastroenterol 1996; 91:2367-2371.
34. Agrawal NM, Roth S, Graham DY, White RH, Germain B, Brown JA, Stromatt SC: Misoprostol compared with sucralfate in the prevention of nonsteroidal anti-inflammatory drug-induced gastric ulcer. A randomized, controlled trial. Ann Intern Med 1991; 115:195-200:
35. Graham DY, Agrawal NM, Roth SH: Prevention of NSAIDs-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial. Lancet 1988; 2:1277-80.
36. Suzuki T, Yoshida N, Nakabe N, Isozaki Y, Kajikawa H, Takagi T, Handa O, Kokura S, Ichikawa H, Naito Y, Matsui H, Yoshikawa T: Prophylactic effect of rebamipide on aspirin-induced gastric lesions and disruption of tight junctional protein zonula occludens-1 distribution. J Pharmacol Sci. 2008;106:469-77.
37. Lai KC, Lam SK, Chu KM, Wong BC, Hui WM, Hu WH, Lau GK, Wong WM, Yuen MF, Chan AO, Lai CL, Wong J: Lansoprazole for prevention of recurrences of ulcer complications from long-term low dose aspirin use. N Engl J Med 2002; 346:2033-2038.